Nutrition Chemicals MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy Ingredient CategoryBy FormBy Distribution Channel

Nutrition chemicals are the amino acids, vitamins, antioxidants, enzymes and related additive compounds blended into animal feed, food, pharmaceutical, household, cosmetic and personal care formulations to supply nutritional or functional properties the base product does not otherwise carry. Buyers are feed and food manufacturers, pharmaceutical and nutraceutical formulators, and personal care and cosmetics producers who purchase these chemicals as raw material inputs rather than as finished consumer products. The chemicals are supplied in dry, powder or liquid form depending on how the buyer's own manufacturing process handles blending.

The global nutrition chemicals market stood at USD 12.65 billion in 2025. A forecast-period rate of 6.94% takes it to USD 23.12 billion by 2034, and the study reports every year in between, passing USD 9.72 billion in 2020, USD 12.02 billion in 2024, USD 13.52 billion in 2026 and USD 17.67 billion in 2030.

On the type axis, growth rates run from 6.07% for Animal up to 8.3% for Plant. Animal carries the volume: USD 5.31 billion and 41.98% of revenue in 2025, USD 9.02 billion and 39.01% in 2034. The lines gaining share are Plant. Animal and Food lose share without losing revenue.

The application split puts Agriculture first, at USD 4.3 billion and 33.99% of revenue in 2025, rising to USD 7.4 billion and 32.01% in 2034. Personal Care grows faster at 8.77% against 6.22%, moving from 12.02% of revenue to 14.01% by 2034. It cuts the same total as the type axis from a different commercial angle, so revenue does not add across the two.

Asia Pacific is the largest region at 38.02% of 2025 revenue, worth USD 4.81 billion and reaching USD 9.48 billion by 2034. North America follows at 27.04%, moving from USD 3.42 billion to USD 5.78 billion, and Middle East and Africa is the smallest at 4.98%. Because Asia Pacific, Latin America and Middle East and Africa take share, the revenue added by 2034 concentrates instead of spreading across all five regions.

Coverage extends to five regions, three type lines and five segmentation axes over the full fifteen years. The 2025 total itself is arrived at by triangulating published aggregates against category proxies, not by an independent count, and the splits below are estimated on that same basis, a bound on their precision worth carrying into any use of them.

• A forecast-period rate of 6.94% takes the market from USD 12.65 billion in 2025 to USD 23.12 billion in 2034, against 5.41% recorded over the 2020-2025 historical period.
• Animal is the largest type line at USD 5.31 billion in 2025, a 41.98% share, reaching USD 9.02 billion and 39.01% of revenue by 2034.
• Fastest growth on the type axis belongs to Plant: 8.3% a year, USD 4.17 billion to USD 8.55 billion, and a share moving from 32.96% to 36.98%.
• Against a base case of USD 23.12 billion in 2034, the study also reports a bear case at USD 20.31 billion and a bull case at USD 26.15 billion, with the assumptions behind each set out separately.
• 38.02% of 2025 revenue is generated in Asia Pacific, worth USD 4.81 billion and rising to USD 9.48 billion by 2034; Middle East and Africa is smallest at 4.98%.
• 39.92% of Asia Pacific's base-year revenue comes from China alone: USD 1.92 billion in 2025, rising to USD 3.89 billion by 2034, which is why it is that region's worked example.
• Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.

Three movements define the forecast period in the global nutrition chemicals market: how the type mix changes, where regional weight shifts, and the rate at which the total compounds.

The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; what separates them is which takes the larger part of the growth.

The type mix tilts toward Plant. Between 2026 and 2034, 8.3% growth in Plant against 6.07% in Animal pulls the type mix apart. Plant takes its share of revenue from 32.96% to 36.98% while Animal gives up ground, from 41.98% to 39.01%. The revenue figures behind that are USD 4.17 billion to USD 8.55 billion and USD 5.31 billion to USD 9.02 billion. Both expand; where a supplier sits on the axis still decides whether it tracks the market.

Growth concentrates in Asia Pacific, Latin America and Middle East and Africa. Asia Pacific moves from 38.02% of revenue in 2025 to 41% in 2034, worth USD 4.81 billion rising to USD 9.48 billion; Latin America moves from 7.98% of revenue in 2025 to 8.52% in 2034, worth USD 1.01 billion rising to USD 1.97 billion; Middle East and Africa moves from 4.98% of revenue in 2025 to 5.49% in 2034, worth USD 0.63 billion rising to USD 1.27 billion. Share moves off the others in turn: North America at 27.04% moving to 25%, Europe at 21.98% moving to 19.98%, each still growing in revenue terms. That makes the regional split worth reading directly instead of scaling from the global rate: the same market rate produces different outcomes depending on where a supplier's revenue sits.

A continuation, not an inflection. Fifteen years of revenue run USD 9.72 billion in 2020, USD 12.02 billion in 2024, USD 12.65 billion in 2025, USD 13.52 billion in 2026, USD 17.67 billion in 2030 and USD 23.12 billion in 2034. No year breaks the trajectory, and the 6.94% forecast rate compares with 5.41% recorded over 2020-2025, a continuation, not an inflection. For a participant that makes planning a question of capturing a share of steady expansion instead of timing a discontinuity, and it is why the type and regional mixes matter more to a forecast than the headline rate does.

Plant carries the market's growth rate

Three sources account for the growth to 2034: 6.94% compounding across the base, share moving toward the faster type lines, and above-market expansion in the leading regions.

Downside case: USD 20.31 billion by 2034, against USD 23.12 billion in the base case

What the bull case turns on

Revenue is concentrated in Animal

In Asia Pacific, 38.02% of global revenue puts 2025 at USD 4.81 billion with USD 9.48 billion projected for 2034. By revenue it sits first across the study, and the ranking does not change between 2025 and 2034.

Its share rises to 41% over the forecast period, at a pace above the 6.94% global rate, so this region warrants separate treatment and should not be scaled off the total.

Animal leads here as it does globally, at 41.98% of 2025 revenue, and Plant again grows fastest at 8.3%. Per-axis and per-country detail for Asia Pacific sits in the full report.

China is the largest market within Asia Pacific, generating USD 1.92 billion in 2025 and projected to reach USD 3.89 billion by 2034. Its 39.92% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Regional revenue of USD 4.81 billion in 2025 and USD 9.48 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

The type pattern in China is the global one: 41.98% of 2025 revenue in Animal, 39.01% by 2034, against 8.3% growth in Plant taking it from 32.96% to 36.98%. Because the country carries 39.92% of Asia Pacific, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. The full report reports China by type separately.

Nutrition chemicals destined for food or dietary use in China fall under the food safety law administered by the National Health Commission, which sets the permitted-use standards a supplier's ingredient must match before it can enter a formulation. The State Administration for Market Regulation enforces conformity at the point of sale, and any chemical without an established status in the national food safety standards must go through a new-ingredient safety review before use. Where the same chemical is sold for animal feed rather than human food, the Ministry of Agriculture and Rural Affairs governs registration and permitted-additive listing instead. Labelling must state the substance's standardized name and its approved function, and importers separately need customs clearance confirming the shipment matches its declared use category.

The suppliers tracked in this study (BASF, DOW Chemical, Vertellus, Evonik Industries, DUPont, TATA Chemicals, FMC Corporation, Cognis, AIC, DSM and Others.) compete in China across the type lines above. Volume sits in Animal at 41.98% of 2025 revenue; movement sits in Plant at 8.3% growth. The full report covers country-level positioning and shares company by company; this summary does not.

9.09% of global revenue is generated in India; USD 1.15 billion in 2025, reaching USD 2.46 billion in 2034, and 23.91% of Asia Pacific.

Japan is sized at USD 0.87 billion in 2025, rising to USD 1.52 billion by 2034; 6.88% of global revenue and 18.09% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.

In North America, 27.04% of global revenue puts 2025 at USD 3.42 billion on the way to USD 5.78 billion by 2034. Among the five regions it ranks second by revenue in both years.

25% of global revenue sits here in 2034, below the 2025 level, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Animal leads here as it does globally, at 41.98% of 2025 revenue, and Plant again grows fastest at 8.3%. The full report breaks North America out along every axis and by country.

The largest single market in North America is the United States, at USD 2.67 billion in 2025 and USD 4.45 billion in 2034. Because it is 78.07% of the region in the base year, North America's totals move with this one country instead of a spread of them. Against regional totals of USD 3.42 billion in 2025 and USD 5.78 billion in 2034, it is the country the full report breaks out in detail.

The type pattern in the United States is the global one: 41.98% of 2025 revenue in Animal, 39.01% by 2034, against 8.3% growth in Plant taking it from 32.96% to 36.98%. Because the country carries 78.07% of North America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-type revenue for the United States appears on its own in the full report.

In the United States, a nutrition chemical intended for food or dietary supplement use is governed by the Food and Drug Administration under the Federal Food, Drug, and Cosmetic Act. A supplier must establish that the substance is generally recognized as safe for its intended use, or hold an approved food additive status, before it can be marketed for that purpose; dietary ingredients sold as supplements instead follow the notification and manufacturing practice requirements set out for that category. Labelling must identify the ingredient and its intended function without implying an unapproved therapeutic claim. Where the same chemistry is supplied for animal feed, the Center for Veterinary Medicine and the state-adopted feed ingredient definitions maintained through AAFCO govern registration and permitted use instead.

The suppliers tracked in this study (BASF, DOW Chemical, Vertellus, Evonik Industries, DUPont, TATA Chemicals, FMC Corporation, Cognis, AIC, DSM and Others.) compete in the United States across the type lines above. The commercially relevant division is 41.98% of 2025 revenue in Animal, where the volume is, against 8.3% growth in Plant, where share moves. Weighting toward North America means competing for 27.04% of 2025 global revenue, a base of USD 3.42 billion moving to USD 5.78 billion across the forecast period.

Within North America, Canada accounts for 21.93% of regional revenue and 5.93% of the global total, worth USD 0.75 billion in 2025 and USD 1.33 billion by 2034.

21.98% of the global nutrition chemicals market sits in Europe in 2025, worth USD 2.78 billion on the way to USD 4.62 billion by 2034. That makes it the third-largest region covered, in 2025 and again in 2034.

By 2034 the share stands at 19.98%, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.

Within the region the type split tracks the global one; 41.98% of 2025 revenue in Animal, fastest growth of 8.3% in Plant. Europe is reported axis by axis and country by country in the full study.

USD 0.78 billion of Europe's 2025 revenue is generated in Germany, the region's largest market, reaching USD 1.25 billion by 2034. 28.06% of the region in the base year makes it the largest market here without making it the region. Against regional totals of USD 2.78 billion in 2025 and USD 4.62 billion in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is Animal at 41.98% of 2025 revenue, easing to 39.01% by 2034, and the fastest is Plant at 8.3%, from 32.96% to 36.98%. Because the country carries 28.06% of Europe, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. The full report reports Germany by type separately.

Germany applies the European Union's harmonized framework for nutrition chemicals, so the operative rules are set at Union level and enforced domestically by the Federal Office of Consumer Protection and Food Safety. A substance used in food must appear on the relevant permitted list under the EU food additive or novel food framework, with safety established through the European Food Safety Authority's opinion process before national enforcement applies. Feed-grade chemistry instead falls under the EU's feed additive authorization regime, which sets its own approval and labelling conditions. Suppliers must label the substance's authorized name and function and keep documentation showing the ingredient's origin and specification match what was authorized, since a national authority checks conformity rather than granting a separate domestic approval.

Competition in Germany runs between the suppliers this study tracks: BASF, DOW Chemical, Vertellus, Evonik Industries, DUPont, TATA Chemicals, FMC Corporation, Cognis, AIC, DSM and Others.. Animal, at 41.98% of 2025 revenue, is where the volume sits, and Plant, growing at 8.3%, is where position changes hands over the forecast period. That makes Europe a 21.98% share of 2025 global revenue, USD 2.78 billion rising to USD 4.62 billion, for any supplier deciding where to concentrate.

France is sized at USD 0.61 billion in 2025, rising to USD 0.97 billion by 2034; 4.82% of global revenue and 21.94% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

Within Europe, the United Kingdom accounts for 20.14% of regional revenue and 4.43% of the global total, worth USD 0.56 billion in 2025 and USD 0.88 billion by 2034.

USD 1.01 billion of 2025 revenue is generated in Latin America, 7.98% of the global nutrition chemicals market rising to USD 1.97 billion in 2034. By revenue it sits fourth across the study, and the ranking does not change between 2025 and 2034.

By 2034 the share has moved up to 8.52%, because it outgrows the market's 6.94%; the revenue added here is disproportionate to where the region started.

Segment composition follows the global pattern: Animal largest at 41.98% of 2025 revenue, Plant fastest at 8.3%. Per-axis and per-country detail for Latin America sits in the full report.

Brazil is the largest market within Latin America, generating USD 0.56 billion in 2025 and projected to reach USD 1.06 billion by 2034. At 55.45% of the region in 2025 it leads, but a majority of Latin America's revenue is generated in other markets. The region itself runs USD 1.01 billion to USD 1.97 billion over the same period, and this is the market carrying the country-level detail in the full report.

The type pattern in Brazil is the global one: 41.98% of 2025 revenue in Animal, 39.01% by 2034, against 8.3% growth in Plant taking it from 32.96% to 36.98%. With 55.45% of Latin America concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports Brazil by type separately.

Brazil regulates nutrition chemicals for human food and supplement use through ANVISA, the national health surveillance agency, which maintains the technical standards a substance must meet before it can be added to a food or supplement formulation and requires registration or notification depending on the ingredient's category. Labelling must disclose the substance's function and comply with ANVISA's rules on nutrient and additive declaration. Where the chemical is intended for animal nutrition rather than human consumption, oversight passes instead to the Ministry of Agriculture and Livestock, which maintains its own registration and permitted-additive lists for feed use. Importers must show that a shipment's documentation and specification correspond to the category under which it was registered before customs release.

Competition in Brazil runs between the suppliers this study tracks: BASF, DOW Chemical, Vertellus, Evonik Industries, DUPont, TATA Chemicals, FMC Corporation, Cognis, AIC, DSM and Others.. Two different problems sit on the same axis: holding Animal at 41.98% of 2025 revenue, and taking Plant while it grows at 8.3%. Weighting toward Latin America means competing for 7.98% of 2025 global revenue, a base of USD 1.01 billion moving to USD 1.97 billion across the forecast period.

Mexico is sized at USD 0.3 billion in 2025, rising to USD 0.57 billion by 2034; 2.37% of global revenue and 29.7% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.

4.98% of the global nutrition chemicals market sits in Middle East and Africa in 2025, worth USD 0.63 billion rising to USD 1.27 billion in 2034. Among the five regions it ranks fifth by revenue in both years.

5.49% of global revenue sits here by 2034, up from the 2025 level, on growth above the market's own 6.94%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

Animal leads here as it does globally, at 41.98% of 2025 revenue, and Plant again grows fastest at 8.3%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.

34.92% of Middle East and Africa's base-year revenue comes from Saudi Arabia; USD 0.22 billion, rising to USD 0.43 billion by 2034. Its 34.92% of base-year regional revenue leads the region, though enough sits elsewhere that Middle East and Africa is not a proxy for it. Set against USD 0.63 billion and USD 1.27 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

Saudi Arabia buys along the same lines as the market globally; Animal first at 41.98% of 2025 revenue and 39.01% in 2034, Plant fastest at 8.3% on a share moving from 32.96% to 36.98%. Its 34.92% weight in Middle East and Africa means those movements carry straight into the regional totals. Per-type revenue for Saudi Arabia appears on its own in the full report.

The Saudi Food and Drug Authority is the primary body governing nutrition chemicals sold into food, supplement, or feed applications within the Kingdom, setting the registration route a supplier must complete before an ingredient can be marketed. Products must also conform to the relevant technical regulations issued through the Gulf Standardization Organization, which apply across the wider Gulf market and are adopted into Saudi national requirements. Labelling must state the substance's identity, function, and any handling conditions in the form the authority specifies, and an importer typically needs the ingredient's registration confirmed before customs clearance is granted. Feed-grade nutrition chemicals are assessed against the same conformity structure, with agricultural authorities involved where the end use is animal nutrition rather than direct human consumption.

Competition in Saudi Arabia runs between the suppliers this study tracks: BASF, DOW Chemical, Vertellus, Evonik Industries, DUPont, TATA Chemicals, FMC Corporation, Cognis, AIC, DSM and Others.. Animal, at 41.98% of 2025 revenue, is where the volume sits, and Plant, growing at 8.3%, is where position changes hands over the forecast period. That makes Middle East and Africa a 4.98% share of 2025 global revenue, USD 0.63 billion rising to USD 1.27 billion, for any supplier deciding where to concentrate.

South Africa is sized at USD 0.14 billion in 2025, rising to USD 0.27 billion by 2034; 1.11% of global revenue and 22.22% of Middle East and Africa. It is reported separately from Saudi Arabia across every segmentation axis in the full report.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by type, application, ingredient category, form, distribution channel, and regional analysis covers Asia Pacific, North America, Europe, Latin America, Middle East and Africa, each broken out by country.